The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.

Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.

Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.

Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.

Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.

Elevated levels of cardiac markers typically indicate heart muscle damage or stress, such as that caused by a heart attack.

No special preparation is required. Inform your healthcare provider about any medications or symptoms you are experiencing.

Results are usually available within a few hours. Rapid testing is critical for timely diagnosis and treatment.

While it is highly effective for diagnosing myocardial infarction and assessing heart damage, it may need to be combined with other tests for comprehensive evaluation.

Discuss abnormal results with your healthcare provider to determine the appropriate next steps for treatment or further evaluation.

A positive result indicates past infection with the Dengue virus or successful vaccination against Dengue.

No, additional tests, such as Dengue IgM or PCR, may be required to differentiate recent infections from past ones.

No, the Dengue IgG test is not suitable for diagnosing acute Dengue infection. IgG antibodies appear later in the course of infection.

Dengue IgG antibodies can remain detectable in the bloodstream for months to years after infection or vaccination.

A negative result suggests no detectable Dengue IgG antibodies. If symptoms persist or there is a recent exposure, consult a healthcare provider for further evaluation.